Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma

*Departments of Laboratory Medicine and Pathology

§Quantitative Health Sciences

‡Division of Hematology, Mayo Clinic, Rochester, MN

†Department of Pathology, University of Yamanashi, Chuo, Yamanashi Prefecture, Japan

Conflicts of Interest and Source of Funding: Supported by P01 CA229100, P30 CA15083, P50 CA97274, and UL1 TR002377 from the National Institutes of Health; and by TRP 6574-19 from the Leukemia & Lymphoma Society. A.L.F. receives research funding from Seattle Genetics, is an inventor of technology discussed in this manuscript for which Mayo Clinic holds an unlicensed patent, and has intellectual property licensed to Zeno Pharmaceuticals. R.P.K. is an inventor of technology discussed in this manuscript for which Mayo Clinic holds an unlicensed patent. For the remaining authors none were declared.

Correspondence: Andrew L. Feldman, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 (e-mail: [email protected]).

留言 (0)

沒有登入
gif